Antiplatelet therapy and coronary artery bypass graft surgery: Perioperative safety and efficacy

Expert Opinion on Drug Safety

Volumn 8, Issue 2, 2009, Pages 169-182

  Kulik, Alexander ^b   Chan, Vincent ^a   Ruel, Marc ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b University of Ottawa Heart Institute ^*

Author keywords

Antiplatelet therapy; Coronary artery bypass graft surgery

Indexed keywords

ACETYLSALICYLIC ACID; ACEXAMIC ACID; APROTININ; CLOPIDOGREL; DIPYRIDAMOLE; FRESH FROZEN PLASMA; PLACEBO; SULFINPYRAZONE; TRANEXAMIC ACID; WARFARIN; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; BLEEDING TIME; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; GRAFT OCCLUSION; GRAFT PATENCY; HEART INFARCTION; HEMATOTHORAX; HUMAN; INTESTINE INFARCTION; INTRAOCULAR HEMORRHAGE; ISCHEMIA; KIDNEY FAILURE; LOW DRUG DOSE; LUNG INJURY; META ANALYSIS; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; PREVALENCE; REOPERATION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STROKE; SURVIVAL; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; DRUG ADMINISTRATION; DRUG COMBINATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL;

ASPIRIN; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; META-ANALYSIS AS TOPIC; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TICLOPIDINE;

EID: 66949153649     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330902797081     Document Type: Review

References (113)

1. Clappers N, Brouwer MA, Verheugt FW. Antiplatelet treatment for coronary heart disease. Heart 2007;93:258-265 (Pubitemid 46180312)
2. Fuster V, Dyken ML, Vokonas PS, et al. Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. Circulation 1993;87:659-675 (Pubitemid 23040943)
3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86 • This meta-analysis summarizes the impressive effects of antiplatelet therapy from 287 randomized controlled studies involving > 200,000 patients with atherosclerotic disease.
4. Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995;11:221-227
5. Zimmermann N, Kienzle P, Weber AA, et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001;121:982-984 (Pubitemid 33733634)
6. Yilmaz MB, Balbay Y, Caldir V, et al. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 2005;115:25-29 (Pubitemid 39572751)
7. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. Jama 2005;294:2446-2454 (Pubitemid 41627922)
8. Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001;409:202-207 (Pubitemid 32144286)
9. Chevigne M, David JL, Rigo P, et al. Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. Ann Thorac Surg 1984;37:371-378 (Pubitemid 14138285)
10. Limet R, David JL, Magotteaux P, et al. Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. J Thorac Cardiovasc Surg 1987;94:773-783 (Pubitemid 17163563)
11. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100:1667-1672 (Pubitemid 29477278)
12. Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823-2828 (Pubitemid 30396013)
13. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502 • This randomized controlled trial demonstrated that the addition of clopidogrel to aspirin improves outcomes in patients presenting with acute coronary syndrome. (Pubitemid 32758501)
14. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 2002;288:2411-2420 • This study showed that the addition of clopidogrel to aspirin for 1 year after percutaneous coronary intervention reduced the risk of death, myocardial infarction and stroke, compared to aspirin therapy alone. (Pubitemid 35340537)
15. Gibbs NM, Weightman WM, Thackray NM, et al. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:55-59 (Pubitemid 32172684)
16. Michelson EL, Morganroth J, Torosian M, et al. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 1978;76:694-697 (Pubitemid 9061879)
17. Taggart DP, Siddiqui A, Wheatley DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990;50:424-428 (Pubitemid 20363914)
18. Ferraris VA, Ferraris SP, Joseph O, et al. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002;235:820-827 (Pubitemid 34547300)
19. Bashein G, Nessly ML, Rice AL, et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. Arch Intern Med 1991;151:89-93
20. Rawitscher RE, Jones JW, McCoy TA, et al. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery. J Cardiovasc Surg (Torino) 1991;32:1-7
21. Reich DL, Patel GC, Vela-Cantos F, et al. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 1994;79:4-8 (Pubitemid 24203423)
22. Vuylsteke A, Oduro A, Cardan E, et al. Effect of aspirin in coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1997;11:831-834 (Pubitemid 27523085)
23. Srinivasan AK, Grayson AD, Pullan DM, et al. Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg 2003;76:41-45 (Pubitemid 36826653)
24. Schonberger JP, Bredee JJ, van Oeveren W, et al. Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin. J Thorac Cardiovasc Surg 1993;106:262-267 (Pubitemid 23243244)
25. Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-561 (Pubitemid 24070876)
26. Tabuchi N, Huet RC, Sturk A, et al. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass. Ann Thorac Surg 1994;58:1036-1039 (Pubitemid 24342426)
27. Landymore RW, Murphy JT, Lummis H, et al. The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. Eur J Cardiothorac Surg 1997;11:798-800 (Pubitemid 27180163)
28. Ivert T, Intonti M, Stain-Malmgren R, et al. Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid. Scand Cardiovasc J 1998;32:289-295 (Pubitemid 28510641)
29. Moran SV, Lema G, Medel J, et al. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery. Perfusion 2000;15:105-110 (Pubitemid 30182410)
30. Pleym H, Stenseth R, Wahba A, et al. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg 2003;96:923-928, table of contents (Pubitemid 36359017)
31. Bybee KA, Powell BD, Valeti U, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005;112:I286-92 (Pubitemid 41266689)
32. Ferraris VA, Ferraris SP, Lough FC, et al. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:71-74 (Pubitemid 18034673)
33. Kallis P, Tooze JA, Talbot S, et al. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss-a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994;8:404-409
34. Ghaffarinejad MH, Fazelifar AF, Shirvani SM, et al. The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery. Cardiol J 2007;14:453-457 (Pubitemid 351278433)
35. Sethi GK, Copeland JG, Goldman S, et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on antiplatelet therapy. J Am Coll Cardiol 1990;15:15-20
36. Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg 2007;22:247-256 (Pubitemid 46683959)
37. Sun JC, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 2008;29:1057-1071 (Pubitemid 351858412)
38. Goldman S, Copeland J, Moritz T, et al. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 1991;84:520-526
39. Hockings BE, Ireland MA, Gotch-Martin KF, et al. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency. Med J Aust 1993;159:376-378 (Pubitemid 23318795)
40. Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000;70:1986-1990 •• This case-control observational study demonstrated that CABG patients who ingested aspirin in 7 days of surgery were significantly less likely to experience perioperative mortality. (Pubitemid 32015295)
41. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17 •• In this observational study involving 5022 CABG patients, aspirin therapy within 48 h after surgery was associated with a significant reduction in the risk of death, myocardial infarction, stroke, renal failure and bowel infarction.
42. Gerrah R, Elami A, Stamler A, et al. Preoperative aspirin administration improves oxygenation in patients undergoing coronary artery bypass grafting. Chest 2005;127:1622-1626 (Pubitemid 46218786)
43. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:e340-437 (Pubitemid 39328205)
44. Ferraris VA, Ferraris SP, Moliterno DJ, et al. The society of thoracic surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 2005;79:1454-1461 (Pubitemid 40431898)
45. Grubitzsch H, Wollert HG, Eckel L. Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements? Cardiovasc Surg 2001;9:510-516
46. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001;29:2271-2275 (Pubitemid 34038157)
47. Hongo RH, Ley J, Dick SE, et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002;40:231-237 (Pubitemid 34756281)
48. Genoni M, Tavakoli R, Hofer C, et al. Clopidogrel before urgent coronary artery bypass graft. J Thorac Cardiovasc Surg 2003;126:288-289 (Pubitemid 36909971)
49. Gansera B, Schmidtler F, Spiliopoulos K, et al. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy. Thorac Cardiovasc Surg 2003;51:185-189 (Pubitemid 37229331)
50. Ray JG, Deniz S, Olivieri A, et al. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord 2003;3:3 (Pubitemid 38824819)
51. Englberger L, Faeh B, Berdat PA, et al. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;26:96-101 (Pubitemid 38759931)
52. Chen L, Bracey AW, Radovancevic R, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004;128:425-431 (Pubitemid 39194700)
53. Kapetanakis EI, Medlam DA, Boyce SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 2005;26:576-583
54. Leong JY, Baker RA, Shah PJ, et al. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 2005;80:928-933 (Pubitemid 41196786)
55. von Heymann C, Redlich U, Moritz M, et al. Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. Thorac Cardiovasc Surg 2005;53:341-345 (Pubitemid 41783569)
56. Kapetanakis EI, Medlam DA, Petro KR, et al. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation 2006;113:1667-1674
57. Haydar AA, Abchee AB, El H II, et al. Bleeding post coronary artery bypass surgery. Clopidogrel-cure or culprit? J Med Liban 2006;54:11-16
58. Picker SM, Kaleta T, Hekmat K, et al. Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome. Eur J Anaesthesiol 2007;24:332-339 (Pubitemid 46270967)
59. Kang W, Theman TE, Reed JF 3rd, et al. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery. J Surg Educ 2007;64:88-92 (Pubitemid 46488891)
60. Filsoufi F, Rahmanian PB, Castillo JG, et al. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements. J Cardiothorac Vasc Anesth 2008;22:60-66
61. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008;34:127-131
62. Ascione R, Ghosh A, Rogers CA, et al. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg 2005;79:1210-1216 (Pubitemid 40431840)
63. Chu MW, Wilson SR, Novick RJ, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-1541
64. Karabulut H, Toraman F, Evrenkaya S, et al. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur J Cardiothorac Surg 2004;25:419-423 (Pubitemid 38340580)
65. Woo YJ, Grand T, Valettas N. Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration. Heart Surg Forum 2003;6:282-285 (Pubitemid 37304568)
66. Shim JK, Choi YS, Oh YJ, et al. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007;134:59-64 (Pubitemid 46962043)
67. Song SW, Youn YN, Yi G, et al. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome. Circ J 2008;72:626-632 (Pubitemid 351679417)
68. Purkayastha S, Athanasiou T, Malinovski V, et al. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis. Heart 2006;92:531-532 •• This meta-analysis of 11 observational studies involving 4002 CABG patients demonstrated that preoperative clopidogrel independently increased perioperative blood loss and the need for re-exploration.
69. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) Trial. Circulation 2004;110:1202-1208 • This post hoc analysis of the CURE Trial showed that the combination of clopidogrel and aspirin reduced the incidence of ischemic complications in acute coronary syndrome patients awaiting CABG, but no benefit was seen with clopidogrel after surgery. (Pubitemid 39202333)
70. McLean DS, Sabatine MS, Guo W, et al. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28. J Thromb Thrombolysis 2007;24:85-91
71. Akowuah E, Shrivastava V, Jamnadas B, et al. Comparison of two strategies for the management of antiplatelet therapy during urgent surgery. Ann Thorac Surg 2005;80:149-152 •• This randomized trial illustrated that a strategy of continuing aspirin and clopidogrel up to the time of surgery with the administration of intraoperative aprotinin reduces blood loss more effectively than a strategy of withholding antiplatelet therapy and not administering aprotinin. (Pubitemid 40840200)
72. van der Linden J, Lindvall G, Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 2005;112:I276-80 •• The administration of intraoperative aprotinin to patients who received clopidogrel within 5 days before CABG reduced postoperative blood loss in this placebo-controlled randomized trial. (Pubitemid 41266687)
73. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-2331 (Pubitemid 351749156)
74. Martin K, Wiesner G, Breuer T, et al. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008;107:1783-1790
75. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-365 (Pubitemid 43145060)
76. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the management of patients with unstable angina). Circulation 2002;106:1893-1900
77. Mehta RH, Roe MT, Mulgund J, et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006;48:281-286
78. Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 1991;83:1526-1533
79. Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 1982;307:73-78 (Pubitemid 12082584)
80. Sanz G, Pajaron A, Alegria E, et al. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Espanol para el Seguimiento del Injerto Coronario (GESIC). Circulation 1990;82:765-773 (Pubitemid 20316727)
81. Pantely GA, Goodnight SH Jr, Rahimtoola SH, et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med 1979;301:962-966 (Pubitemid 10204245)
82. McEnany MT, Salzman EW, Mundth ED, et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg 1982;83:81-89 (Pubitemid 12209553)
83. Sharma GV, Khuri SF, Josa M, et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Circulation 1983;68:II218-21
84. Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med 1984;310:209-214 • This randomized trial showed that the combination of aspirin and dipyridamole for 1 year after CABG significantly improved saphenous vein graft patency compared to placebo. (Pubitemid 14221958)
85. Lorenz RL, Schacky CV, Weber M, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1984;1:1261-1264
86. Brooks N, Wright J, Sturridge M, et al. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. Br Heart J 1985;53:201-207 (Pubitemid 15053141)
87. Rajah SM, Salter MC, Donaldson DR, et al. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg 1985;90:373-377 (Pubitemid 15239239)
88. Pfisterer M, Burkart F, Jockers G, et al. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet 1989;2:1-7 (Pubitemid 19158159)
89. Pfisterer M, Burkart F, Jockers G, et al. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long? Thromb Res Suppl 1990;12:11-21
90. van der Meer J, Hillege HL, Kootstra GJ, et al. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet 1993;342:257-264 (Pubitemid 23224418)
91. Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 1988;77:1324-32 •• In this placebo-controlled randomized trial involving 772 CABG patients, postoperative aspirin significantly improved saphenous vein graft patency 60 days after surgery. (Pubitemid 18141133)
92. Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation 1989;80:1190-1197
93. Goldman S, Copeland J, Moritz T, et al. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 1994;89:1138-1143
94. Fremes SE, Levinton C, Naylor CD, et al. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg 1993;7:169-180 •• This meta-analysis summarizing 17 randomized controlled trials confirmed that postoperative aspirin significantly improves vein graft patency after CABG.
95. Lim E, Ali Z, Ali A, et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ 2003;327:1309 (Pubitemid 37510450)
96. Johnson WD, Kayser KL, Hartz AJ, et al. Aspirin use and survival after coronary bypass surgery. Am Heart J 1992;123:603-608
97. Galea J, Manche A, Goiti JJ, et al. Omission of aspirin in patients following coronary artery bypass graft surgery. J Clin Pharm Ther 1994;19:381-386 (Pubitemid 24369410)
98. Bradshaw PJ, Jamrozik K, Gilfillan I, et al. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Am Heart J 2004;147:1047-1053 (Pubitemid 38880962)
99. Shennib H, Endo M, Benhameid O. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting. Heart Surg Forum 2003;6:288-291 (Pubitemid 37309283)
100. Gurbuz AT, Zia AA, Vuran AC, et al. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 2006;29:190-5 • In this observational study comparing clopidogrel and aspirin to aspirin alone after off-pump CABG, the combination therapy significantly reduced postoperative symptom recurrence and adverse cardiac events.
101. Halkos ME, Cooper WA, Petersen R, et al. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg 2006;81:815-819 (Pubitemid 43247644)
102. Chan V, Kulik A, Bourke ME, et al. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery. J Card Surg 2007;22:493-497 (Pubitemid 350182364)
103. Ibrahim K, Tjomsland O, Halvorsen D, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. Heart Surg Forum 2006;9:E581-856 (Pubitemid 46070564)
104. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-1339 (Pubitemid 26383772)
105. Bhatt DL, Chew DP, Hirsch AT, et al. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001;103:363-368 (Pubitemid 32105974)
106. Saw J, Topol EJ, Steinhubl SR, et al. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. Am J Cardiol 2004;94:623-625 (Pubitemid 39165841)
107. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American heart association task force on practice guidelines (Writing committee to revise the 2002 guidelines for the management of patients with unstable Angina/Non ST-Elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: endorsed by the American association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation 2007;116:e148-304
108. Dacey LJ. Preoperative and immediate postoperative aspirin also reduces morbidity: reply. Ann Thorac Surg 2001;72:1797-1798 (Pubitemid 33049825)
109. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007;4:CD001886 (Pubitemid 351816827)
110. Ferguson TB Jr, Hammill BG, Peterson ED, et al. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of thoracic surgeons. Ann Thorac Surg 2002;73:480-9; discussion 9-90
111. Kulik A, Le May M, Wells GA, et al. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med 2005;6:15 (Pubitemid 41554976)
112. Clopidogrel and Aspirin after Surgery for Coronary Artery Disease Study (NCT00776477). ClinicalTrials.gov Web site. Available from: http://www. clinicaltrials.gov/ct2/show/NCT00776477. [Accessed 10 November 2008]
113. Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting (PAPA CABG) Study (NCT00330772). ClinicalTrials.gov Web site. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00330772. [Accessed 10 November 2008]